<DOC>
	<DOC>NCT00282984</DOC>
	<brief_summary>The primary purpose of this study is to determine whether or not varenicline will help people with cardiovascular disease quit smoking and to confirm it is safe in these patients.</brief_summary>
	<brief_title>Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Participants must have stable, documented cardiovascular disease (including at least one of the following diagnosed &gt; 2 months prior to the Screening visit angina, myocardial infarction (MI), revascularization, transient ischemic attack (TIA), and peripheral vascular disease (PVD). Participants that smoke &gt; 10 cigarettes / day. Participants with unstable cardiovascular disease Cardiovascular events in the past 2 months Moderate or severe chronic obstructive pulmonary disease (COPD)</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>